Literature DB >> 17412842

Best practices: The development of the Social Cognition and Interaction Training program for schizophrenia spectrum disorders.

David L Penn1, David L Roberts, Dennis Combs, Abram Sterne.   

Abstract

This column describes the development of a treatment, the Social Cognition and Interaction Training (SCIT) program, a group-based intervention delivered weekly over a six-month period, with the purpose of improving both social cognition and social functioning among persons with schizophrenia spectrum disorders. SCIT comprises three phases: emotion training, figuring out situations, and integration. Initial pilot testing of 17 inpatients showed that SCIT was associated with improved emotion perception, improved theory of mind, and a reduced tendency to attribute hostile intent to others, with effect sizes being in the medium-large range. Although research is still in the early phases, SCIT is a potential best practice.

Entities:  

Mesh:

Year:  2007        PMID: 17412842     DOI: 10.1176/ps.2007.58.4.449

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  64 in total

Review 1.  Vocational, social, and cognitive rehabilitation for individuals diagnosed with schizophrenia: a review of recent research and trends.

Authors:  Seth Kurzban; Lisa Davis; John S Brekke
Journal:  Curr Psychiatry Rep       Date:  2010-08       Impact factor: 5.285

2.  Social Disconnection in Schizophrenia and the General Community.

Authors:  Michael F Green; William P Horan; Junghee Lee; Amanda McCleery; L Felice Reddy; Jonathan K Wynn
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

3.  Adapting social neuroscience measures for schizophrenia clinical trials, Part 1: ferrying paradigms across perilous waters.

Authors:  Michael F Green; Junghee Lee; Kevin N Ochsner
Journal:  Schizophr Bull       Date:  2013-09-26       Impact factor: 9.306

4.  Social Cognitive Skills Training for Psychosis With Community-Based Training Exercises: A Randomized Controlled Trial.

Authors:  William P Horan; Michelle Dolinsky; Junghee Lee; Robert S Kern; Gerhard Hellemann; Catherine A Sugar; Shirley M Glynn; Michael F Green
Journal:  Schizophr Bull       Date:  2018-10-17       Impact factor: 9.306

5.  Theatre improvisation training to promote social cognition: A novel recovery-oriented intervention for youths at clinical risk for psychosis.

Authors:  Sunny X Tang; Kevin H Seelaus; Tyler M Moore; Jerome Taylor; Carol Moog; David O'Connor; Marla Burkholder; Christian G Kohler; Paul M Grant; Dvora Eliash; Monica E Calkins; Raquel E Gur; Ruben C Gur
Journal:  Early Interv Psychiatry       Date:  2019-06-09       Impact factor: 2.732

6.  Social cognitive training for schizophrenia: a meta-analytic investigation of controlled research.

Authors:  Matthew M Kurtz; Christi L Richardson
Journal:  Schizophr Bull       Date:  2011-04-27       Impact factor: 9.306

7.  Mentalizing Errors in Patients with Schizophrenia Who Received Psychosocial Rehabilitation: a Case-Control Study.

Authors:  Nelson Andrade-González; Miriam Sarasa; Araceli García-López; Israel Leonés; Tate F Halverson; Guillermo Lahera
Journal:  Psychiatr Q       Date:  2021-01-06

Review 8.  Psychosocial treatments to promote functional recovery in schizophrenia.

Authors:  Robert S Kern; Shirley M Glynn; William P Horan; Stephen R Marder
Journal:  Schizophr Bull       Date:  2009-01-27       Impact factor: 9.306

9.  Call it a monster for lack of anything else: narrative insight in psychosis.

Authors:  David Roe; Ilanit Hasson-Ohayon; Shlomo Kravetz; Phil T Yanos; Paul H Lysaker
Journal:  J Nerv Ment Dis       Date:  2008-12       Impact factor: 2.254

10.  A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis.

Authors:  Cristina Cacciotti-Saija; Robyn Langdon; Philip B Ward; Ian B Hickie; Elizabeth M Scott; Sharon L Naismith; Loretta Moore; Gail A Alvares; Marie Antoinette Redoblado Hodge; Adam J Guastella
Journal:  Schizophr Bull       Date:  2014-06-23       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.